Trials / Completed
CompletedNCT00770523
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients With Hematologic Malignancies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Cooperative Study Group A for Hematology · Network
- Sex
- All
- Age
- 15 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.
Detailed description
Primary end points are treatment-related mortality and engraftment. Secondary end points are regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.
Conditions
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2008-03-01
- Completion
- 2008-12-01
- First posted
- 2008-10-10
- Last updated
- 2011-06-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00770523. Inclusion in this directory is not an endorsement.